Dr RR Baliga's "Got Knowledge Doc" Podkast

🩺💊 Which blood pressure medications do patients tolerate best?   A major JAMA network meta-analysis of 716 randomized trials involving 159,362 participants found important differences in adverse effects and treatment discontinuation across antihypertensive regimens.   🏆 ARB + CCB combinations ranked as the most tolerated therapy. ✅ ARB-containing regimens consistently performed best. ⚠️ CCBs w...

🧬 Aging leaves a molecular fingerprint—and we can now read it.   A remarkable Nature study analyzed >11,000 transcriptomes across mice, rats, macaques, and humans to identify universal transcriptomic hallmarks of ageing. The investigators developed highly accurate gene-expression clocks that predict biological age, mortality risk, lifespan modulation, and responses to rejuvenation interventions....

🫀 Coronary microvascular dysfunction is no longer a "hidden" diagnosis.   The new FLOW-CMD Registry published in The Lancet demonstrates that coronary microvascular dysfunction frequently coexists with obstructive coronary artery disease and significantly increases adverse cardiovascular outcomes.   Patients with CMD had: ⚠️ Higher cardiac death ⚠️ More repeat revascularization ⚠️ Increased heart...

🫀 Fascinating new study in the The New England Journal of Medicine explores "Stem-Cell–Derived Biologic Ventricular Assist Tissue (BioVAT)" for advanced heart failure. Investigators demonstrated that engineered heart-muscle patches derived from induced pluripotent stem cells increased ventricular wall thickness, modestly improved left ventricular ejection fraction, and enhanced quality of life in...

🧬 Could a single infusion replace decades of lipid-lowering therapy?   The new NEJM study on VERVE-102 explores in vivo base editing of PCSK9 using CRISPR-inspired adenine base editing technology. In this phase 1 trial, a one-time infusion produced LDL cholesterol reductions up to 62% with durable effects extending beyond 1 year. ❤️   This may represent a major shift from chronic pharmacotherapy...

⚕️ Long before modern preventive medicine, Diocles of Carystus emphasized something remarkably familiar today: hygiene, exercise, balanced diet, sleep, and daily discipline. A physician of 4th century BCE Greece, Diocles helped advance anatomy, surgery, nutrition, and holistic health. Some ancient sources even credit him with being among the first to use the term "anatomy." 🧠 His philosophy was s...

⚖️🚀 RETATRUTIDE may redefine obesity medicine.   In the Phase 3 TRIUMPH-1 trial, Lilly's triple agonist (GIP/GLP-1/glucagon) achieved an astonishing 28.3% average weight loss at 80 weeks, with some patients exceeding 30% weight reduction — territory once associated mainly with bariatric surgery. 📉   Even the 4 mg dose achieved nearly 20% weight loss with fewer discontinuations. Significant impro...

🧪 New in JAMA: 4% tetrasodium EDTA significantly reduced ICU catheter complications in a multicenter randomized clinical trial.   Among 1,468 critically ill patients, EDTA locking solution lowered the composite risk of bloodstream infection, catheter occlusion requiring alteplase, and catheter removal due to occlusion. The strongest signal? Fewer catheter blockages and smoother ICU workflow. 💉🏥...

🌙🧠 Fascinating new insights from Science reveal that sleep is far more than "rest." During non-rapid eye movement sleep, neuromodulators synchronize into ~50-second oscillatory rhythms that coordinate vascular pulsations, cerebrospinal fluid flow, and glymphatic clearance of amyloid-β and tau.   This elegant systems-level biology may explain why aging, psychiatric disease, stress, cardiovascular...

🧪❤️ Are preservatives in ultra-processed foods quietly increasing cardiovascular risk?   A major analysis from the NutriNet-Santé cohort published in the European Heart Journal followed >112,000 participants and linked several commonly used food additives with higher rates of hypertension and cardiovascular disease.   Notable signals emerged for sodium nitrite, potassium sorbate, sulphites, eryth...

🦠 The INTEGRAL-1 trial in The Lancet delivers exciting data for resistant urinary tract infections. Cefepime–nacubactam achieved both noninferiority AND superiority vs imipenem–cilastatin in complicated UTI and acute pyelonephritis.   ⚡ Strong microbiological eradication, promising ESBL activity, and favorable safety profiles suggest an important future role in carbapenem-sparing strategies.   #...

😴💊 Could a pill transform the treatment of obstructive sleep apnea?   The SynAIRgy Phase 3 trial of AD109 (aroxybutynin + atomoxetine) showed significant reductions in apnea–hypopnea index and hypoxic burden in patients unable to tolerate CPAP therapy. 🌙🫁   A once-nightly oral therapy targeting upper airway neuromuscular dysfunction may represent a new frontier in sleep medicine. Fascinating d...

⚕️ "If you want to understand the health of a population, look at the air they breathe, the water they drink, and the places where they live."   More than 2,400 years ago, Hippocrates transformed medicine by arguing that disease had natural—not supernatural—causes. His emphasis on clinical observation, ethics, prognosis, professionalism, and compassionate care laid the foundation for modern medici...

💊 Can weight loss achieved with injectable GLP-1 therapies be maintained using an oral agent?   The ATTAIN-MAINTAIN phase 3b trial published in Nature Medicine evaluated once-daily oral orforglipron after prior tirzepatide or semaglutide therapy. Patients maintained substantially more prior weight reduction versus placebo over 52 weeks, while preserving cardiometabolic benefits. 🌍⚖️   A fascinat...

👁️ New NEJM correspondence highlights a potentially important ophthalmic signal linked to dulaglutide therapy. Two patients developed choroidal lymphoid hyperplasia with painless visual loss within months of GLP-1 receptor agonist initiation. Remarkably, ocular and systemic findings rapidly resolved after stopping dulaglutide. As GLP-1 therapies expand across diabetes, obesity, and cardiometabolic...

🫀 Scar. Signal. Survival.   A major new JAMA study from the NHLBI Hypertrophic Cardiomyopathy Registry followed 2,698 patients for nearly 7 years and demonstrated that advanced cardiac magnetic resonance imaging and NT-proBNP markedly improve prediction of adverse outcomes in hypertrophic cardiomyopathy.   📌 Key findings: • Late gadolinium enhancement (fibrosis burden) strongly predicted events...

🧠 Six landmark stroke investigations published in NEJM, JAMA, and Lancet are redefining modern reperfusion science.   🔹 ORIENTAL-MeVO: Thrombectomy improved outcomes in selected medium-vessel occlusion strokes. 🔹 TNK-PLUS: Bridging tenecteplase before EVT in the late window showed no added benefit. 🔹 CHOICE-2: Intra-arterial alteplase after successful thrombectomy improved excellent recovery b...

😴🧠 How much sleep is "just right" for healthy ageing? A remarkable Nature study of ~500,000 UK Biobank participants demonstrated a striking U-shaped relationship between sleep duration and biological ageing across 23 ageing clocks, 17 organs, and 3 omics platforms. 🌙🧬 Both short ( 8 h) sleep were associated with accelerated ageing, higher systemic disease burden, and increased all-cause mortal...

🫀 Old drug. New evidence. Renewed relevance. Two major JAMA studies published in 2026 revisit the role of digoxin/digitalis glycosides in modern cardiovascular care. 📊 A meta-analysis of 9,013 patients with HFmrEF/HFrEF showed reduced worsening heart failure events without increased mortality. 🌍 The Dig-RHD randomized trial from India demonstrated that digoxin reduced death or worsening heart f...

🐍⚕️ Before modern hospitals, there were the healing temples of Asclepius — where medicine, ritual, dreams, and compassion converged.   Son of Apollo, trained by the wise centaur Chiron, Asclepius became the enduring symbol of healing in Greek civilization. His daughters — Hygieia, Panacea, and Iaso — represented health, cure, and recovery itself.   Even today, the Rod of Asclepius remains the uni...

🧬 Predict. Prevent. Protect: The APOL1 Proteomic Revolution A fascinating new study in Nature Medicine describes a 9-protein APOL1 Proteomic Risk Score (APRS) capable of predicting kidney disease progression years before chronic kidney disease becomes clinically apparent. Among individuals of African ancestry with APOL1 high-risk genotypes and preserved kidney function, APRS achieved a remarkable...

🧠🎙️ New infographic from Dr RR Baliga's Podkast for the Kurious Doc: "Colonoscopy, Cancer & Competing Risks."   Two major 2026 studies from The Lancet and JAMA reshape how we think about colorectal cancer screening and surveillance.   🔹 The NordICC trial showed reduced colorectal cancer incidence with colonoscopy, but no significant mortality reduction after 13 years. 🔹 In adults ≥75 years with...

🧠 Three major stroke trials published in JAMA this week may reshape adjunctive reperfusion strategies in acute ischemic stroke.   🔹 TNK-PLUS: Tenecteplase before thrombectomy in late-window stroke showed no added functional benefit. 🔹 CHOICE-2: Intra-arterial alteplase after successful thrombectomy improved excellent neurological recovery, though mortality signals warrant caution. 🔹 INSTANT: E...

🧬 Tumours are not just masses of cells—they are organized ecosystems.   A remarkable Nature study by Zhang et al. mapped >10 million spatial transcriptomes across cancers and identified 9 conserved "spatial ecotypes" within the tumour microenvironment. Even more striking: these ecotypes could be detected non-invasively from plasma cell-free DNA using deep learning.   Higher SE7/SE8 predicted bett...

🧠💤 Can the unconscious brain still process meaning? A remarkable Nature study used Neuropixels recordings from the human hippocampus during general anesthesia and found preserved oddball detection, semantic encoding, syntactic processing, and even prediction of upcoming words. The anesthetized brain was not silent—it adapted, learned, and contextualized language despite loss of consciousness. Th...